“Does the dose of hydroxyurea correlate with shorter hospital stay and higher fetal hemoglobin levels in patients with sickle cell disease?”
High-dose HU was linked to shorter hospital stays and favorable hematologic outcomes in adults with SCD.
Authors
- Farjah H AlGahtani (ORCID: https://orcid.org/0000-0002-6552-6260)
- Jawahir M. Abuhaimed (ORCID: https://orcid.org/0000-0002-1822-063X)
- Abdulmajeed Alshabanat (ORCID: https://orcid.org/0000-0001-8594-5051)
- Aamer Aleem (ORCID: https://orcid.org/0000-0001-5774-0358)
- Hind Abdullah Aloraier
- Ibrahim Alrumaih
- Maha Z Alamri
- Sarah Sewaralthahab (ORCID: https://orcid.org/0000-0001-6682-9709)
- Yara Alzahrani
- Ghazi Alotaibi (ORCID: https://orcid.org/0000-0002-6902-1876)
- Nouran Khalid Arnous (ORCID: https://orcid.org/0009-0008-9910-7524)
- Abdulaziz B Albacker
- Rawan Altamimi
- Maram Alharbi
- Fatima Alshalti
- Musa Fares Alzahrani
- Ahmad Jamal
Institutions
- Alfaisal University (SA)
- King Saud Medical City (SA)
- King Saud University (SA)
- Health First (US)
- Ministry of Health (SI)
Publication Details
- Journal
- Future Science OA
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1080/20565623.2025.2610223
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00